Cys-loop ligand-gated ion channels mediate rapid neurotransmission throughout the central nervous system. They possess agonist recognition sites and allosteric sites where modulators regulate ion channel function. Using strychnine-sensitive glycine receptors, we identified a scaffold of hydrophobic residues enabling allosteric communication between glycine-agonist binding loops A and D, and the Zn 2+ -inhibition site. Mutating these hydrophobic residues disrupted Zn 2+ inhibition, generating novel Zn 2+ -activated receptors and spontaneous channel activity. Homology modeling and electrophysiology revealed that these phenomena are caused by disruption to three residues on the '-' loop face of the Zn 2+ -inhibition site, and to D84 and D86, on a neighboring b3 strand, forming a Zn 2+ -activation site. We provide a new view for the activation of a Cys-loop receptor where, following agonist binding, the hydrophobic core and interfacial loops reorganize in a concerted fashion to induce downstream gating.
The Cys-loop ligand-gated ion channel superfamily includes the nicotinic acetylcholine receptor (nAChR), g-aminobutyric acid type A receptor (GABA A R), glycine receptor (GlyR) and serotonin type 3 receptor (5HT 3 R). Each subunit of these pentamers contains three domains: a ligand binding extracellular domain (ECD), formed by a sandwich of two b-sheets; a four a-helical membrane-spanning domain; and an intracellular region of unspecified quaternary structure 1 . The interior of the ECD is hydrophobic 2, 3 , and, as for most globular proteins, it is considered to be an entropic stabilizer of protein folding 4 . Given the presumed stability of this hydrophobic core and its location between two sheets of rigid b-strands, it is usually regarded as a relatively inflexible structure. Thus, after agonistinduced activation, the core would move, if at all, as a rigid body 5 . Accordingly, it would be the agonist binding loops A-F, supported by the surrounding rigid b-strands, that would undergo a conformational change upon agonist binding to trigger rigid body movement and downstream channel opening 2, [6] [7] [8] [9] [10] [11] . An alternative view, based on structural and modeling data, suggests that substantial portions of the inner and outer b-sheets of the ECD shift their orientation relative to one another upon receptor activation 1, 12 . Given the location of the hydrophobic core between the inner and outer b-sheets of each ECD, it would then be expected that the core would reorganize, rather than move as a rigid body, to facilitate the reorientation of the b-sheets [13] [14] [15] [16] [17] . This movement may induce separation of important charge interactions along neighboring receptor subunit interfaces, allowing the ECDs to twist and induce downstream channel opening 8, 16, 18, 19 .
An ideal model system to investigate the role of the hydrophobic core in Cys-loop receptor activation is that involving Zn 2+ inhibition of GlyR. These receptors readily form homomers that are modulated by the physiological cation Zn 2+ in a biphasic fashion. Zn 2+ can be found in nanomolar concentrations in external medium and is also packaged into vesicles and released at synapses in sufficient amounts to endogenously modulate GlyRs, with low micromolar concentrations potentiating submaximal glycine responses and higher concentrations causing inhibition [20] [21] [22] . Two Zn 2+ binding sites have been identified: the potentiation site is contained solely on the outer b-sheet of the ECD 23 , whereas the inhibition site spans neighboring subunits on the inner b-sheet of the ECDs [24] [25] [26] (Fig. 1a-c) . Inhibition by Zn 2+ of GlyR function involves the stabilization of charge interactions between neighboring subunit ECD interfaces, thereby hindering their movement. This supports the notion that charge separation of neighboring ECD interfaces is necessary for receptor activation and that agonist binding must transduce a signal near to the Zn 2+ -inhibition site to evoke a conformational change in this area, leading to receptor activation. As the hydrophobic core is located between the glycine binding site and the Zn 2+ -inhibition site, identifying the molecular requirements for Zn 2+ inhibition will elucidate the roles of the hydrophobic core and the subunit ECD interface in receptor function.
Here we demonstrate that a cluster of residues forming a scaffold across the hydrophobic core are crucial for Zn 2+ inhibition and spontaneous opening of the human GlyR ion channel. Spontaneous opening was attributed to the apparent flexibility of a loop on the '-' face of the Zn 2+ -inhibition site, which is exquisitely sensitive to the molecular composition of the hydrophobic core. Disruption of this loop and the discovery of previously uncharacterized elements in a neighboring b3 strand that are also important for receptor activation demonstrate that charge redistribution at the ECD inner subunit interface is a key component of GlyR activation.
RESULTS
Hydrophobic residues are required for Zn 2+ inhibition A GlyR homology model was constructed to guide our site-directed mutagenesis studies into receptor activation. The GlyR protein sequence was first aligned with other Cys-loop receptors. This revealed that the region encompassing the GlyR Zn 2+ -inhibition site is not conserved across any of the Cys-loop receptors, for which atomicresolution ECD templates are available, and, furthermore, that this region contains a two to three amino acid insertion. Structural alignment of three ECD template structures (conotoxin-bound Aplysia californica acetylcholine binding protein (Ac-AChBP 27 ); Torpedo (Tor) nAChR a 1 (ref. 1); and mouse nAChR a1 subunit 14 ), revealed substantial structural variation at the two loops of the '+' and '-' face 28 flanking the b5 strand (nomenclature of ref. 2; Supplementary  Fig. 1 online) , which corresponds to the Zn 2+ -inhibition site. Using the variable loop regions as insertion points for the extra residues in our GlyR alignment (Fig. 1a) allowed us to generate a GlyR homology model (MODELLER-9.2 (ref. 29); based on the TornAChR a 1 template) with His107 and His109 exposed at the subunit interface 25 and Phe108 solvent accessible 30 , in accordance with published data.
To probe the link between Zn 2+ inhibition and GlyR activation, hydrophobic residues positioned between the Zn 2+ -inhibition site, defined by His107, His109, Thr112 and Thr133 (refs. 24,26,31) , and the three closest agonist binding loops (A, D and E; Fig. 1b,c) , were substituted with alanine. Substituted GlyRs were expressed in human embryonic kidney (HEK) cells, and their sensitivities to Zn 2+ potentiation and inhibition were assessed by whole-cell recording of glycine-evoked responses (EC 50 ) in the presence of increasing concentrations of Zn 2+ . Substituting residues at the Zn 2+ -inhibition site '-' face (b5 F108A, I111A; b6¢ I132A, L134A) and the loop A face (L98A, F99A, F100A) substantially reduced sensitivity to Zn 2+ inhibition compared to the wild type, whereas Zn 2+ potentiation remained the same (Fig. 1d,e) . Substitutions in agonist binding loop D (V60A, I62A, L64A) also reduced Zn 2+ inhibition, with I62A causing ablation. This residue is orientated in the GlyR model toward other residues required for Zn 2+ inhibition from loop A (Leu98, Phe99, Phe100) and those from b5 and b6¢ adjoining the Zn 2+ -inhibition site (Phe108, Ile111, Ile132, Leu134). By contrast, substituting distally located hydrophobic residues in agonist binding loop E (L117A and L118A; Fig. 1e and Table 1 ; I120A did not traffic to the cell surface ( Supplementary Fig. 2 online) and other hydrophobic residues located away from loops A and D and b5 and b6¢ ( Supplementary  Fig. 3 and Supplementary Table 1 online) did not disrupt Zn 2+ inhibition. All the substituted receptors with attenuated Zn 2+ inhibition retained glycine EC 50 s within ten-fold of the wild-type ( Table 1) and comparable maximal glycine currents (I max ) and Hill slopes, with the exception of a1 F99A (I max ¼ 3.9 ± 0.4 nA; wild-type GlyR I max ¼ 6.8 ± 0.5 nA; P o 0.01).
Removing Zn 2+ inhibition creates Zn 2+ -activated GlyRs Although Zn 2+ does not activate wild-type GABA A R or GlyRs, it generated inward currents at GlyRs with impaired Zn 2+ inhibition, that is, those with alanine substitutions in the glycine binding loops A and D and Zn 2+ -inhibition binding strands b5 and b6¢ (L98A, F99A, Figure 1 Hydrophobic determinants of Zn 2+ inhibition. (a) Partial protein alignment of Cys-loop receptor ECDs showing GlyR a1 hydrophobic residues that are examined (red), positions where hydrophobicity is retained in other Cys-loop receptors (red), conserved residues (boxed), and the GlyR Zn 2+ -inhibition binding site residues (underlined). Hydrophobic motifs are labeled and color coded in accordance with b and c. (b,c) The GlyR a1 ECD homology model based on Tor nAChRa 1 (ref. 1). Clustered hydrophobic residues (orange) connect the Zn 2+ -inhibition site at the inner-subunit interface (black and light blue motifs-note, the black motif is not a b-strand in the model but is referred to as such in main text for clarity 2 ) to glycine binding loops A (green), D (dark blue) and E (mauve) of the outer-subunit interface. Zn 2+ inhibition-site residues His107, His109, Thr112 and Thr133 are in gray (nitrogen atoms are blue and oxygens are red). Dotted line depicts the interface with '+' and '-' subunit sides 28 . Glycine, displayed in CPK, spacefill, was fitted manually in accordance with ref. 35 ; Zn 2+ , fitted manually in gray spacefill. Exact side chain orientations presented here are speculative, based on best alignment and modeling estimations. Inset, the blue box shows a pentamer plan view showing the viewing angle (arrow) for the main picture and revealing the separation between the Zn 2+ binding site (gray circle) and glycine binding site (mauve circle); the black box shows and enlarged plan view of the interface shown. (d,e) Zn 2+ -concentration response curves for modulation of EC 50 glycine currents on wild-type (WT; dashed line) and alanine-substituted receptors. a1 I120A did not traffic to the cell surface, so no recordings were made ( Supplementary Fig. 2 ). Curves were fitted with the Hill equation. All points are means ± s.e.m. (n ¼ 3-6). Fig. 2a) . The Zn 2+ -activated currents reversed close to the Cl -equilibrium potential (E Cl ) (0.4 ± 1.4 mV, n ¼ 5), and the current-voltage relationships were comparable to those for glycine-activated Cl -currents at wild-type GlyRs (Fig. 2b) . Zn 2+ -concentration response curves revealed that the potency and relative efficacy (maximal Zn 2+ response as a percentage of maximal glycine response in the same cell) varied substantially between the substituted receptors ( Fig. 2c and Table 1 ). a1 L134A showed the highest sensitivity to Zn 2+ (EC 50 ¼ 0.06 ± 0.01 mM, n ¼ 5), whereas a1 F99A showed the highest relative efficacy (86 ± 13%, n ¼ 5). By contrast, a1 I62A supported only 3 ± 1% maximal activation with 1 mM Zn 2+ ( Fig. 2c and Table 1 ). Entirely consistent with Zn 2+ activating the substituted GlyRs, the anion-selective channel blocker cyanotriphenylborate (CTB, 20 mM) abolished the Zn 2+ -activated currents (Fig. 2d) . Furthermore, both strychnine, a selective GlyR competitive antagonist, and picrotoxin (PTX), a GABA A R and GlyR 50 Zn 2+ responses were large enough to be recorded reliably, and the glycine I-V for the wildtype (WT) receptor. (c) Zn 2+ activation-response curves for alanine-substituted GlyRs; Zn 2+ maxima are normalized to glycine maxima (10 mM) in the same cell. (d) Representative a1 F108A Zn 2+ I max (100 mM) current, co-applied with and without 20 mM CTB. Inhibition greater than 100% is due to additional background leak (discussed later in Fig. 6 ). (e,f) a1 L98A concentration-inhibition curves for strychnine and picrotoxin, respectively, on glycine-or Zn 2+ -activated EC 50 currents (n ¼ 3-6). Wild-type receptor activation sensitivities to the antagonists are shown in orange.
allosteric blocker, also inhibited Zn 2+ activation (Fig. 2e,f) . This prompted the classification of these substituted GlyRs as Zn 2+ -activated GlyRs (ZAGs).
Hydrophobicity and sensitivity to Zn 2+ inhibition
To investigate the ZAGs further, we substituted Phe99 and Phe100 of loop A and Phe108 of b5 (Fig. 3a) individually with either tyrosine or tryptophan (both aromatic like phenylalanine) or leucine or methionine (aliphatic). Although many substitutions reduced Zn 2+ inhibition ( Fig. 3b-d) , only some generated ZAG behavior ( Fig. 3e-g ). Of the three phenylalanine residues, we found that Phe100 is the most crucial for maintaining wild-type sensitivity to Zn 2+ inhibition; however, there was no correlation between the properties of the substituting residue and the disruption to Zn 2+ inhibition ( Glycine EC 50 s for a1 Phe100-and Phe108-substituted receptors remained within two-fold of those of the wild type with the exceptions of a1 F100Y and a1 F108W (which increased 15-fold and 25-fold, respectively; P o 0.05; Supplementary Table 2) . For Phe99-substituted receptors, glycine EC 50 s were significantly increased for a1 F99L , a1 F99W and a1 F99Y (3-30-fold; P o 0.05), but surprisingly the a1 F99M receptor was six-fold more sensitive to glycine (wild-type EC 50 ¼ 35 ± 5 mM; a1 F99M EC 50 ¼ 5.5 ± 0.5 mM, n ¼ 4-6; P o 0.05), suggesting an important role for this residue in determining glycine binding. Notably, the GlyR model positions Phe99 facing into the glycine binding site (Fig. 1b,c) . 28 . Glycine (CPK, spacefill) was docked manually 35 ; Zn 2+ is a representation only (gray spacefill). Inset shows the viewing angle (arrow), with Zn 2+ (gray spot) and glycine binding sites (mauve spot). (b) 0.1 mM Zn 2+ activation of alanine-substituted a1 L134A -background GlyRs, expressed as a percentage GlyI max in the same cell. (c) Zn 2+ activation-concentration response curves for a1 L134A, D84A , a1 L134A, D86A and a1 L134A, D97A receptors normalized to the glycine I max and also normalized to the Zn 2+ I max (inset). (d) Zn 2+ -activation response curves for the equivalent mutations on an a1 F99A background showing that, although Asp84 and Asp86 are still required for Zn 2+ activation, Asp97 is not (n ¼ 3-6).
substitution of Zn 2+ binding residues with non-Zn 2+ -coordinating alanines at either the Zn 2+ -inhibition or Zn 2+ -potentiation sites revealed that neither site was required for Zn 2+ activation (Supplementary Fig. 4 online) . Given that Zn 2+ inhibition was severely compromised in ZAGs, we reasoned that regions bordering the inhibition site may have become structurally perturbed, sufficient to form a new Zn 2+ -activation site.
On an a1 L134A ZAG background (most Zn 2+ -sensitive ZAG), potential Zn 2+ -coordinating residues neighboring the Zn 2+ -inhibition site were substituted with alanine and assessed for activation by 0.1 mM Zn 2+ (EC 70 for a1 L134A ; Fig. 4a,b) . Of these substitutions, Asp84, Asp86 (strand b3) and Asp97 (loop A) virtually abolished Zn 2+ activation from 38 ± 9% (a1 L134A ) to 5 ± 1% (a1 L134A D84A ) and 2.4 ± 1.2% (a1 L134A D86A ), with no detectable activation for a1 L134A D97A (Fig. 4c) . The Zn 2+ EC 50 s for a1 L134A D84A and a1 L134A D86A were increased 120-fold and 15-fold, respectively (Fig. 4c,  inset) , whereas glycine EC 50 s were shifted only two-fold (Supplementary Table 3 online). Notably, using a wild-type receptor background, the substitutions D84A, D86A or D97A caused only modest (otwo-fold) changes in GlyR sensitivity to Zn 2+ inhibition and potentiation ( Supplementary Fig. 5 and Supplementary Table 4 online).
According to the GlyR homology model (Fig. 4a ), Asp84 and Asp86 are positioned approximately 17 Å from Asp97, too far for the three residues to coordinate a single Zn 2+ ion 32 . Furthermore, Asp97, which is conserved across the Cys-loop receptor family, probably supports loop B via the carboxyl side chain 33 , precluding its involvement in Zn 2+ binding. To establish the importance of Asp84, Asp86 and Asp97 for Zn 2+ activation, alanine substitutions were also made on an alternative ZAG background, a1 F99A (the most efficacious ZAG). Substituting Asp84 or Asp86 again substantially reduced the sensitivity to Zn 2+ activation, but substituting Asp97 was ineffective (Fig. 4d) . Thus, the role of Asp97 in Zn 2+ activation is more complex than can be explained by just its direct binding of Zn 2+ .
Zn 2+ -activation site is not a potentiation site As reagents and water are ubiquitously contaminated with glycine (B50 nM 34 ), it is feasible that Asp84 and Asp86 may actually form part of a (second) Zn 2+ -potentiation site, rather than an activation site. Occupancy of this site by Zn 2+ would then enhance the receptor's sensitivity to glycine, allowing activation by low contaminating glycine concentrations. To address this, an a1 L134A ZAG background was used with an extra mutation, E157A on glycine binding loop B 35 , to produce a receptor with a 50-fold-reduced sensitivity to glycine. Using this mutant, the threshold concentration for glycine was now 4100 mM (Fig. 5a ) and 2,000-fold higher than the predicted level of glycine contamination. Nevertheless, the a1 L134 E157A ZAG showed only a modest three-fold reduced sensitivity to Zn 2+ activation (Fig. 5b) and retained comparable maximal responses to Zn 2+ (Fig. 5c) . Using an alternative F99A background, a1 F99A E157A showed identical Zn 2+ sensitivity to a1 F99A , despite being insensitive up to 10 mM glycine (Fig. 5d,e) . Thus, in the absence of glycine-mediated activation, Zn 2+ activation is still apparent, suggesting that it originates from a pure activation site, not an additional Zn 2+ -potentiation site.
ZAGs show spontaneous channel activity HEK cells expressing the most sensitive ZAGs, a1 L98A , a1 F99A , a1 F108A and a1 L134A , all showed sizable (0.5-3 nA) leak currents. A minor component was caused by Zn 2+ contamination of the external solution (B200 nM 36 ) activating the ZAGs, as this was reduced by the Zn 2+ chelators, tricine (2.5 mM) or N,N,N¢,N¢-tetrakis-(2-pyridylmethyl)-ethylenediamine (TPEN (100 mM); Fig. 6a,b) . The remaining component depended on spontaneous GlyR channel activity, because it was abolished by CTB (20 mM) to less than 50 pA standing current (considered full abolition of receptor-mediated leak). Strychnine also attenuated the leak, by 100% for ZAG a1 F99A and by 90 ± 4% for a1 L134A . Strychnine was ten-fold less potent in inhibiting the leak current compared to glycine-activated currents (Fig. 6c,d) .
Notably, Asp84 and Asp86, which are important for Zn 2+ activation, were also required for spontaneous activation, with a1 F99A D84A , a1 F99A D86A , a1 L134A D84A , and a1 L134A D86A failing to show spontaneous channel activity (Fig. 6e) . Furthermore, Asp84 and Asp86 also influenced glycine-induced receptor activation, as alanine substitutions induced a modest but consistent two-fold reduction in glycine sensitivity in wild-type, a1 F99A and a1 L134A backgrounds ( Fig. 6f and Supplementary Table 4) . A double-substituted receptor, a1 D84A D86A , was nonfunctional.
To investigate whether spontaneous activity mimics agonistinduced activity, we recorded single-channel currents in cell-attached mode (pipette potential +60 mV) for wild-type channels activated by glycine (20 mM; EC 30 ) and for spontaneously gating a1 F99A ZAGs without glycine. TPEN (100 mM) was present throughout to remove any activation by contaminating Zn 2+ . The single-channel currents for each receptor population were comparable at 4-5 pA, with estimated conductances of B60 pS 37 (Fig. 7a) mean time constants and relative areas (P 4 0.05; Fig. 7b and Table 2 ). The shut-time distributions required five Gaussian components, giving similar time constants (t) for both receptors, with the exception of the shut-time constants t C2 and t C3 , which were two-fold higher for a1 F99A receptors ( Fig. 7c and Table 2 ). These changes will contribute to the lower open probability (P O ) for clusters of openings at a1 F99A (0.53 ± 0.07) compared to wild-type (0.9 ± 0.03, n ¼ 3) channels. With regard to the burst-duration distributions, four Gaussian components were required with comparable time constants and relative areas, except for t B3 , which was two-fold longer for a1 F99A (Fig. 7d) .
The '-' face affects Zn 2+ activation and spontaneous activity Conceivably, Zn 2+ activation and spontaneous channel activity may arise if the substitutions of hydrophobic residues exert a common conformational effect on a region that undergoes crucial movement during channel gating. As the Zn 2+ -inhibition site is perturbed in ZAGs, it is the ideal region to examine for conformational flexibility. The top ten GlyR homology models (lowest distant-dependent atomic statistical potential (DOPE) 38 score from 100 models run in MODELLER-9.2) based on three related template structures, conotoxin-bound Ac-AChBP, TornAChR a 1 and mouse nAChR a1 (refs. 1, 14, 27) , showed much greater structural variability at the '+' and '-' loop faces surrounding the b5 strand of the Zn 2+ -inhibition site, compared to other more rigid b-strands and across the structure as a whole (Fig. 8a , insets, and Supplementary Table 5 online). By using DOPE loop modeling to optimize the structures of the GlyR '+' and '-' face loops, using TornAChR a 1 and mouse nAChR a1 as templates, the ten best conformations for the '+' loops were all comparable (Fig. 8b) , whereas, for the '-' face loops, variable conformations were equally favored with residues showing multiple orientations at this location ( Fig. 8b and Supplementary Table 6 online).
To corroborate the modeling data, polar residues Thr112, Thr113 and Asp114 on the apex of the '-' face, the point of greatest variability between DOPE loop-fitted structures, were individually substituted with alanine and examined for Zn 2+ activation and spontaneous activity. Although T112A yielded a highly sensitive and efficacious 38 of the '+' and '-' Zn 2+ -inhibition site loops starting from the best GlyR a1 model based on two different templates. This revealed one favorable conformation for the '+' face loop for each template-derived model, with only minor deviations in the peptide backbone (red) and side chain positions between models. In contrast, numerous peptide backbone conformations were equally preferred for the '-' face loop (pink or yellow for mouse nAChR a1; aquamarine or purple for Tor nAChR a 1 ) with clear divergence in side chain positions. Original model backbone conformations before loop refinement are shown in translucent red (mouse nAChR a1) and translucent blue (Tor nAChR a 1 ). (c) Zn 2+ activation-response curves from GlyRs with potential Zn 2+ -coordinating residues on the '+' and '-' inhibition site faces substituted with alanines; Zn 2+ maxima are normalized to glycine maximal current (10 mM) in the same cell. Only a1 T112A showed highly sensitive and efficacious ZAG activity. ZAG a1 F99A (orange line; originally from Fig. 2c) is included for comparison. Insets, DOPE loop refinement of GlyR a1 models from mouse nAChR a1 and Tor nAChR a 1 templates show how alternative favorable conformations on the '-' face loop could have a substantive impact on the organization of Thr112 in the Zn 2+ binding site. Zn 2+ was fitted manually (dark gray, spacefill). (d) Significant spontaneous activity, measured as persistent leak currents (I CTB /(I CTB + glycine I max )) in the presence of 100 mM TPEN was observed for GlyR a1 T113G and a1 D114G , where '-' loop flexibility was increased, but not for GlyR a1 T113P and a1 D114P , where flexibility was reduced. (e) Glycine concentration-response curves for receptors with glycine or proline substitutions at positions 112, 113 or 114 in the '-' loop. Glycine increased agonist sensitivity compared to proline substitution at the equivalent position. Glycine curve for wild-type receptors included for comparison (orange line; n ¼ 3-7). ZAG (Fig. 8c) , no single alanine substitution generated a spontaneously active receptor (data not shown). We altered the apex flexibility of the '-' face by individually substituting Thr112, Thr113 and Asp114 with either glycine to increase or proline to reduce backbone flexibility 39, 40 . Whereas the proline-substituted receptors lacked spontaneous activity, two glycine-substituted receptors, a1 T113G and a1 D114G , showed 15 ± 4% and 43 ± 10% (n ¼ 4-6) spontaneous activity, respectively (Fig. 8d) . Furthermore, there was a three-fold increase in glycine sensitivity for a1 T113G (EC 50 ¼ 9 ± 2 mM) and a1 D114G (EC 50 ¼ 10 ± 3 mM) compared to wild type (EC 50 ¼ 35 ± 5 mM; n ¼ 4-6), whereas the proline-substituted receptors all showed reduced sensitivities to glycine (Fig. 8e) . Thus, increasing the flexibility of the '-' face around Thr112-Asp114 increased the propensity of GlyR to open spontaneously and in response to agonist binding, whereas decreasing flexibility by proline substitution had the opposite effect.
DISCUSSION
This study identifies a scaffold of hydrophobic residues in GlyR that functionally link glycine binding loops A and D with the Zn 2+ binding b5 and b6¢ strands of the Zn 2+ -inhibition site. Exchanging the hydrophobic residues, but not others outside the scaffold, initiated spontaneous channel opening, severely attenuated Zn 2+ inhibition and enabled Zn 2+ to act as a novel activator of GlyRs. This suggests that the hydrophobic scaffold is pivotally involved in receptor activation by stabilizing one or more closed GlyR conformations. This is achieved by regulating the '-' loop face of the Zn 2+ -inhibition site, as specific substitutions of polar residues in the '-' face produced receptors with the same properties to those generated by alanine substitutions in the hydrophobic scaffold.
Structurally linking two discrete ligand binding sites
The current view of Cys-loop receptor activation is that agonist binding at the interface between subunits induces a rearrangement of interacting residues, allowing the ECDs to twist relative to one another. The newly orientated loops at the bases of the ECDs then promote rearrangement of opposing transmembrane domains to open the channel 6, 16, 18, [41] [42] [43] [44] . By binding to its interfacial inhibitory site on GlyRs, Zn 2+ stabilizes subunit interfaces, preventing the ECDs from twisting and initiating activation. It is therefore plausible that by distorting the Zn 2+ binding '-' loop interface we will not only ablate Zn 2+ inhibition, but also enable spontaneous channel activity, particularly if the distortion mimics the conformation that occurs in the activated receptor state. Thus, the attenuation of Zn 2+ inhibition and appearance of spontaneous channel activation are intrinsically linked. The extent to which both properties are seen in mutated receptors will depend on the degree to which each substitution perturbs the '-' loop away from a closed and toward an activated conformation.
Notably, the molecular pathway by which Zn 2+ causes inhibition is entirely different to that for Zn 2+ potentiation at GlyRs. The potentiation site resides close to the Cys-loop, where it may interact directly with Thr151 to facilitate channel gating 23 . This negates the need for any interaction with the hydrophobic scaffold identified here, explaining why Zn 2+ potentiation was unaffected in this study.
The molecular pathway identified here is the first to be described in a Cys-loop ligand-gated ion channel that functionally connects two distinct binding sites, linking the agonist binding site to downstream activation. The importance of the hydrophobic scaffold in mediating GlyR activation is emphasized by the common kinetics of spontaneously active a1 F99A and agonist-activated wild-type GlyRs. Specifically, for a1 F99A , it is the alanine substitution that artificially perturbs loop A to induce activation, whereas, for wild-type GlyRs, it is presumably agonist binding that similarly perturbs loop A to cause activation. Although a crucial role for loop A in directing receptor activation is evident for GABA A Rs 45 and nAChRs 46 , loop C, possibly via transmission of a conformational change along the outside of the ECDs (b7, 9 and 10 strands), has also been suggested to mediate activation upon agonist binding 8, 10 . Our data do not preclude this scenario, but advocate loop A as an important contributor to the conformational wave that precedes channel opening 47 .
At the glycine binding site, Phe99 seems ideally positioned to directly influence the receptor's sensitivity to glycine, possibly via a cation-p interaction 48 . The action of Phe99 to induce GlyR activation in response to agonist binding may then be mediated via the hydrophobic scaffold and subsequent '-' loop face of the Zn 2+ -inhibition site. Indeed, Phe99 probably does this via Leu98 and Phe100, which are predicted to face, opposite to Phe99, into the hydrophobic scaffold toward the residues supporting the '-' loop face. Such an interaction with Phe99 would explain why Phe100 could also influence the receptor's sensitivity to glycine (Supplementary Fig. 6 and Supplementary Table 2 online). The ability of Phe99 to influence important residues within the hydrophobic scaffold may explain why it produces the most efficacious ZAG and the most spontaneously active receptors when substituted with alanine.
From the perspective of the polar residues at the Zn 2+ site's '-' loop face, substituting Thr112 or Ile111 produced a receptor that was insensitive to Zn 2+ inhibition (see also refs. 25,31) and capable of Zn 2+ activation. Ile111 faces into the core, in close proximity with the other residues that constitute the hydrophobic scaffold. Thus, Thr112, via Ile111, is ideally located to act as a relay following perturbation of the hydrophobic scaffold. Sequential substitution of Thr113 and Asp114 within the '-' loop by glycine, but not by alanine or proline, also yielded spontaneously active receptors. These residues must also be ideally located to respond to perturbations of the hydrophobic scaffold, with increased loop flexibility enabling the receptor to shift to an activated state, whereas imposed rigidity (for example, proline insertion or Zn 2+ binding, which stabilizes this region) hinders receptor activation.
b5 loop movement during GlyR activation Although we propose that the '-' loop face undergoes a conformational change to facilitate receptor activation, comparative structural evidence does not, so far, support this idea. Overlaying crystal structures of Aplysia californica AChBP bound to either a-conotoxin PnIA ('inactive conformation') or HEPES ('active conformation' 27 ) does not reveal any variation around the corresponding '-' loop face region in the GlyR model ( Supplementary Fig. 7 online) . Furthermore, structurally aligning TornAChR a 1 and a 2 subunits (presumed closed conformation) compared to b, d and g subunits (presumed open) for the pentamer reveals only a small degree of variability around the corresponding '-' loop face region ( Supplementary Fig. 8  online) . Of course, as static structures, it is possible that neither the HEPES-bound AChBP nor bdg TorAChR subunits represent fully activated receptors. Alternatively, they might undergo different conformational rearrangements after activation compared to GlyRs. Simulation studies on nAChRs also do not support movements in the '-' face region 49 , although the nanosecond timescales for these studies are as yet too short to encompass all conformational rearrangements in pentameric Cys-loop receptors.
Despite the caveats, the '-' loop face of the GlyR Zn 2+ -inhibition site was predicted to adopt numerous conformations and side chain orientations with the potential to influence receptor function.
Moreover, previous functional studies support a role for the '-' loop face in the GlyR-activation process: Thr112 is important in determining partial agonist efficacy 50 ; it is also accessible to cysteine-scanning mutagenesis, resulting in dynamic disruption to agonist-evoked responses 30 ; and Zn 2+ binds between subunits at the '-' loop face to stabilize the GlyR closed conformation. These data suggest that this interface is mobile during receptor activation 25, 31 .
Creating a Zn 2+ -activation site The Zn 2+ -activation site was localized to Asp84 or Asp86 on strand b3, directly above the '-' loop face. Structural perturbation of the '-' loop face may therefore have a knock-on effect on the b3 region, allowing Asp84 or Asp86 to form a previously undescribed Zn 2+ binding site that aids movement of the subunit interfaces, rather than hinders them, thereby inducing activation. This provides further evidence that charge dispersal at subunit interfaces has an important role in regulating Cys-loop receptor excitability 16, 19, 46, 51 and also indicates that a dynamic interaction occurs between the '-' loop face and the b3 strand to facilitate activation of wild-type receptors. The variable potency and efficacy of Zn 2+ at different ZAGs further indicates that hydrophobic residues within the scaffold differentially affect the '-' loop face and consequently the juxtaposed b3 strand, so determining the efficiency with which Asp84 or Asp86 forms a new Zn 2+ -activation site.
The general activation mechanism presented here for GlyR is in accordance with the hydrophobic scaffold and '-' loop face dynamically responding to agonist binding. This provides a new vista on Cys-loop receptor activation, whereby during activation the reorganization of the hydrophobic scaffold and '-' face facilitates the realignment of the inner and outer b-sheets relative to one another 12, 13, 16, 18 . This then initiates movement of subunit interfaces, which is subsequently transmitted to the transmembrane domains for receptor activation 42 .
METHODS
cDNA constructs and mutagenesis. We used human GlyR a1L cDNA constructs, and mutant cDNAs were prepared using the Stratagene Quikchange kit. Mutated cDNAs were sequenced using an ABI sequencer.
Cell culture, transfection and electrophysiology. By using a calcium phosphate transfection method (3 GlyR a1:1 eGFP) we expressed GlyR in HEK cells (ATCC CRL1573) grown on poly-L-Lysine-coated coverslips at 10% confluence. Whole-cell membrane currents were recorded after 24 h at 20-22 1C from single HEK cells held at -40 mV using the patch clamp technique (Axopatch 200B, Molecular Devices). For rapid drug applications (exchange rate B50-100 ms), we used a Y-tube. Patch electrodes (4-5 MO) were filled with 140 mM KCl, 2 mM MgCl 2 , 1 mM CaCl 2 , 10 mM HEPES, 11 mM EGTA and 2 mM ATP, pH 7.2 (E300 mOsm). External solution contained 140 mM NaCl, 4.7 mM KCl, 1.2 mM MgCl 2 , 2.5 mM CaCl 2 , 10 mM HEPES and 11 mM D-Glucose, pH 7.4 (E300 mOsm). For GlyRs with nanomolar sensitivities to Zn 2+ activation, we added 2.5 mM tricine (Zn 2+ complexation K d ¼ 10 À5 M 52 ) to the saline to remove Zn 2+ contamination 36 . For single-channel analysis, we used thick-walled electrodes (10-20 MO) filled with external saline solution containing 100 mM TPEN and 10 mM tetraethylammonium (TEA) to block endogenous potassium channel activity. Single-channel recordings were made in cell-attached mode at +60 mV pipette potential.
Data acquisition and analysis. Membrane currents were filtered using a highpass Bessel filter at 3 kHz (-36 dB per octave) and series resistance compensation was routinely achieved up to 70%. Data were recorded in 20-s epochs directly to a Pentium IV, 3.5-GHz computer into Clampex 8.0 via a Digidata 1322A (Axon instruments) sampling at 200-ms intervals. Because of Zn 2+ activation in many of the receptors, Zn 2+ -inhibition profiles were measured by prolonged (4-s) co-application of Zn 2+ with glycine, with response measurements being taken at the 4-s time point (to allow Zn 2+ inhibition sufficient time to reach equilibrium 26 ). We analyzed the digitized membrane-current records offline using Axoscope 8.2. The concentration-response relationships for glycine and Zn 2+ were fitted with modified Hill equations as previously described 26 .
For the single-channel data analyses, stored prefiltered (2.7-kHz Bessel) single-channel data were digitized at 33 kHz before analysis. A fixed time resolution based on the dead time of the system was set at 80 ms. We analyzed the single-channel current amplitudes by fitting Gaussian components to the amplitude distributions to determine the mean single-channel current, s.d. and the total area of the component using a nonlinear least-squares fitting routine. Single-channel conductances were calculated from the mean unitary current and the difference between the patch potential and glycine response reversal potential. The patch potential was estimated in cell-attached recordings by estimating the cell-membrane potential.
All open and shut durations were measured with a 50% threshold cursor applied to the main single-channel current amplitude (WinEDR v2.8.9). The duration of events that were included in the analysis was not less than 200 ms before fitting the dwell-time histograms. Frequency distributions were constructed from the measured individual open and shut durations and analyzed by fitting a mixture of exponentials, defined by equation (1):
ðA i =t i Þ Á expðÀt=tÞ ð 1Þ
where A i represents the area of the ith component to the distribution and t i represents the respective time constant. The areas, time constants and standard errors of the individual components of the distribution were determined. The burst-duration analysis required the determination of a critical shut time (t crit ) 53 determined between the shut-time constants, t C3 and t C4 , by solving equation (2):
Channel-open probability (P O ) was calculated as the percentage of time that the channel spent in the open state within a cluster. All statistical comparisons used an unpaired t-test, and P o 0.05 was considered significant.
Homology and loop modeling. We used ClustalW 54 to produce protein sequence alignments. Aplysia californica acetylcholine binding protein, AcAChBP (PDB 2BR8, the conotoxin-bound form 27 ), TornAChR a 1 bda 2 g (PDB 2BG9) 1 and mouse nAChR a1 (PDB 2QC1) 14 were used for the combinatorial extension structural alignment method 55 , which helped identify divergent regions in the GlyR a1 model. The final alignment reflected both alignment strategies. The TornAChR a 1 subunit was selected as the final template structure to guide the homology modeling of the GlyR a subunit, as it has only two fewer residues around the b5 strand (the GlyR Zn 2+ -inhibition site), compared to three fewer residues for Ac-AChBP; also, the structure of TornAChR a 1 was determined as part of a pentamer, whereas mouse nAChR a1 was crystallized as a nonphysiological monomer with several artificial point mutations 14 . The TornAChR a 1 pentamer was built by overlaying a second a 1 subunit over the a 2 subunit and then using Chimera 56 to build a five-fold symmetrical pentamer. Using MODELLER-9.2 (ref. 29) , 100 human GlyR a1 models were generated with cysteine bridges added into the agonist binding loop C (C198-C209) for the principle TornAChR a 1 pentamer template and also for the Ac-AChBP conotoxin-bound pentamer and the mouse nAChR a1 monomer. Side chain configurations were generated using SCWRL3 (ref. 57) . Fifty loops were generated using DOPE loop modeling in Modeller 9.2, for each loop before ('+') and after ('-') the b5 strand for each of the subunit templates ('+' loop residues 102-NEKGAH-107; '-' loop residues 110-EITTDN-115). Models were evaluated using MolProbity 58 and gave good general agreement with each other. Uncertainty regarding the short b5 strand, ascribed as a b-strand in Ac-AChBP (PDB 1UW6) and nAChR a1 (PDB 2QC1) but not in TornAChR a 1 (PDB 2BG9), was considered unimportant, as it had little effect on side chain positioning, and a PSIPRED 59 secondary-structure prediction of the GlyR sequence gave low confidence for the presence of a b-strand, suggesting that neither template was more likely than the other to be correct. All three-dimensional images were prepared and rendered using Chimera 56 .
